<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03228602</url>
  </required_header>
  <id_info>
    <org_study_id>JACQUIN PEGASE 2016</org_study_id>
    <nct_id>NCT03228602</nct_id>
  </id_info>
  <brief_title>Impaired Gustatory Sensory Perception in Obese and Obese Diabetic Persons</brief_title>
  <acronym>PEGASE</acronym>
  <official_title>Gustatory Evoked Potentials and Cerebral Control of Food Intake in Obese Subjects</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire Dijon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire Dijon</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the study is to compare several parameters in three distinct groups of subjects:&#xD;
      persons with obesity, persons with obesity and diabetes and persons with neither obesity nor&#xD;
      diabetes:&#xD;
&#xD;
        -  the electrical activity in response to a sweet solution, measured before and after a&#xD;
           standard meal, using gustatory evoked potentials (recording explained below)&#xD;
&#xD;
        -  blood hormone levels related to weight gain (insulin, dopamine, ghrelin, leptin:&#xD;
           measured in blood samples)&#xD;
&#xD;
        -  levels of activity and quantity of an enzyme present in the saliva, amylase, which is&#xD;
           able to break down ingested starch into several molecules of glucose.&#xD;
&#xD;
      All of these parameters will be correlated to determine whether the results are different in&#xD;
      the 3 groups of subjects in the study.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 11, 2016</start_date>
  <completion_date type="Anticipated">July 2023</completion_date>
  <primary_completion_date type="Anticipated">July 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Amplitude of the gustatory evoked potential</measure>
    <time_frame>Up to 10 days</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Latency of the gustatory evoked potential</measure>
    <time_frame>Up to 10 days</time_frame>
  </primary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">115</enrollment>
  <condition>Obesity</condition>
  <condition>Diabetes</condition>
  <arm_group>
    <arm_group_label>healthy subjects</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>obese</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>obese diabetic</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>obese diabetic who are going to be operated on</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>25 of a sleeve gastrectomy and 25 of a Y gastric bypass</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Recording of GEP (Gustatory Evoked Potentials)</intervention_name>
    <description>record cerebral activity thanks to electrodes placed on the head and fixed with a painless, harmless adhesive paste and linked to a computer equipped with specific software to interpret the signals obtained. The collection of data for the electric signal takes 20 minutes.</description>
    <arm_group_label>healthy subjects</arm_group_label>
    <arm_group_label>obese</arm_group_label>
    <arm_group_label>obese diabetic</arm_group_label>
    <arm_group_label>obese diabetic who are going to be operated on</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients who have provided written consent&#xD;
&#xD;
          -  Patients over 18 years old&#xD;
&#xD;
          -  Body Mass Index (BMI) &lt;25 kg/m² for healthy volunteers and BMI≥30 kg/m² for obese&#xD;
             subjects&#xD;
&#xD;
          -  Patients with type 2 diabetes for the group &quot;obese diabetic subjects&quot;&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients under guardianship&#xD;
&#xD;
          -  Patients without health insurance cover&#xD;
&#xD;
          -  Pregnant or breast-feeding women&#xD;
&#xD;
          -  Active smokers&#xD;
&#xD;
          -  Subjects with type 2 diabetes for the &quot; healthy subjects &quot; and &quot; obese subjects &quot;,&#xD;
             subjects with type 1 diabetes for all groups&#xD;
&#xD;
          -  Subjects who do not speak French&#xD;
&#xD;
          -  Treatment that interferes with taste or acts on the central nervous system&#xD;
&#xD;
          -  Anti-diabetic treatment with GLP-1 analogues (Glucagon-like peptide 1) or SGLT2&#xD;
             (sodium-glucose cotransporter type 2)&#xD;
&#xD;
          -  Known hypersensitivity to the foods proposed in the study, or the paste used to fix&#xD;
             the electrodes, or to paraffin wax or to the products tested (sucrose, glucose or&#xD;
             starch for the gustatory evoked potentials and triangular tests)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Agnès JACQUIN-PIQUES</last_name>
    <phone>3 80 29 37 54</phone>
    <phone_ext>+33</phone_ext>
    <email>agnes.jacquin-piques@chu-dijon.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>CHU Dijon Bourgogne</name>
      <address>
        <city>Dijon</city>
        <zip>21079</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Agnès JACQUIN-PIQUES</last_name>
      <phone>3 80 29 37 54</phone>
      <phone_ext>+33</phone_ext>
      <email>agnes.jacquin-piques@chu-dijon.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>December 2020</verification_date>
  <study_first_submitted>June 26, 2017</study_first_submitted>
  <study_first_submitted_qc>July 21, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">July 25, 2017</study_first_posted>
  <last_update_submitted>December 16, 2020</last_update_submitted>
  <last_update_submitted_qc>December 16, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">December 19, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

